Segall Bryant & Hamill LLC Sells 6,779 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Segall Bryant & Hamill LLC cut its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 3.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 167,790 shares of the company’s stock after selling 6,779 shares during the quarter. Segall Bryant & Hamill LLC owned approximately 0.41% of Phibro Animal Health worth $3,524,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Rhumbline Advisers raised its stake in Phibro Animal Health by 0.6% during the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after purchasing an additional 484 shares during the period. Los Angeles Capital Management LLC raised its position in shares of Phibro Animal Health by 2.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock valued at $505,000 after buying an additional 503 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Phibro Animal Health by 3.1% in the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after buying an additional 729 shares in the last quarter. New York State Teachers Retirement System boosted its position in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after acquiring an additional 775 shares during the last quarter. Finally, SG Americas Securities LLC grew its stake in Phibro Animal Health by 7.4% during the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock valued at $276,000 after acquiring an additional 906 shares in the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. StockNews.com cut shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday. Morgan Stanley increased their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Finally, Barclays lifted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Stock Up 0.2 %

Shares of NASDAQ PAHC opened at $21.68 on Friday. The stock has a market capitalization of $878.11 million, a price-to-earnings ratio of 45.17, a P/E/G ratio of 0.45 and a beta of 0.58. Phibro Animal Health Co. has a 12-month low of $12.17 and a 12-month high of $26.55. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. The firm’s 50-day moving average price is $22.77 and its 200-day moving average price is $22.65.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, equities research analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.21%. The ex-dividend date of this dividend was Wednesday, March 5th. Phibro Animal Health’s payout ratio is 100.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.